Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May;12(3):e1509.
doi: 10.1002/wnan.1599. Epub 2019 Nov 6.

Nanocarriers in photodynamic therapy-in vitro and in vivo studies

Krzysztof Sztandera  1 , Michał Gorzkiewicz  1 , Barbara Klajnert-Maculewicz  1   2
Affiliations
Review

Nanocarriers in photodynamic therapy-in vitro and in vivo studies

Krzysztof Sztandera et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 May.

Abstract

Photodynamic therapy (PDT) is a minimally invasive technique which has proven to be successful in the treatment of several types of tumors. This relatively simple method exploits three inseparable elements: phototoxic compound (photosensitizer [PS]), light source, and oxygen. Upon irradiation by light with specified wavelength, PS generates reactive oxygen species, which starts the cascade of reactions leading to cell death. The positive therapeutic outcome of PDT may be limited due to several aspects, including low water solubility of PSs, hampering their effective administration and blood circulation, as well as low tumor specificity, inefficient cellular uptake and activation energies requiring prolonged illumination times. One of the promising approaches to overcome these obstacles involves the use of carrier systems modulating pharmacokinetics and pharmacodynamics of the PSs. In the present review, we summarized current in vitro and in vivo studies regarding the use of nanoparticles as potential delivery devices for PSs to enhance their cellular uptake and cytotoxic properties, and thus-the therapeutic outcome of PDT. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease.

Keywords: nanocarriers; photodynamic therapy; photosensitizer; singlet oxygen.

PubMed Disclaimer

References

REFERENCES

    1. Abdel-Kader, M. H. (2014). History of Photodynamic Therapy. In M. H. Abdel-Kader (Ed.), Photodynamic Therapy (pp. 3-22). Berlin, Heidelberg, Germany: Springer. https://doi.org/10.1007/978-3-642-39629-8_1
    1. Abrahamse, H., & Hamblin, M. R. (2016). New photosensitizers for photodynamic therapy. Biochemical Journal, 473(4), 347-364. https://doi.org/10.1042/BJ20150942
    1. Ackroyd, R., Kelty, C., Brown, N., & Reed, M. (2001). The history of photodetection and photodynamic therapy. Photochemistry and Photobiology, 74(5), 656-669. https://doi.org/10.1562/0031-8655(2001)0740656THOPAP2.0.CO2
    1. Agarwal, M. L., Clay, M. E., Harvey, E. J., Evans, H. H., Antunez, A. R., & Oleinick, N. L. (1991). Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Research, 51(21), 5993-5996.
    1. Ali, S. M., & Olivo, M. (2002). Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. International Journal of Oncology, 21(3), 531-540.

Publication types

LinkOut - more resources